For the twelve months ended Sep 30, 2026, Doximity Inc. reported $661.58M of revenue and $139.72M of net income.
DOCS revenue was $174.54M in fiscal Q2 2027 (ended Sep 30, 2026), up 3.6% from a year earlier and up 11.4% from the prior quarter. For the full fiscal 2026 it was $644.86M, up 13.1% from fiscal 2025. Compound annual growth was +25.5% over 5 years. It rose in each of the last 6 fiscal years. Fiscal 2026 is the highest of the 7 fiscal years on file.
DOCS net income was $34.73M in fiscal Q2 2027 (ended Sep 30, 2026), down 44.0% from a year earlier and up 42.8% from the prior quarter. For the full fiscal 2026 it was $196.05M, down 12.2% from fiscal 2025. Compound annual growth was +31.3% over 5 years. It rose in 4 of the last 6 fiscal years.
DOCS diluted EPS was $0.18 in fiscal Q2 2027 (ended Sep 30, 2026), down 41.9% from a year earlier and up 38.5% from the prior quarter. For the full fiscal 2026 it was $0.98, down 11.7% from fiscal 2025.
DOCS free cash flow was $93.28M in fiscal Q2 2027 (ended Sep 30, 2026), down 0.7% from a year earlier and up 122.5% from the prior quarter. For the full fiscal 2026 it was $326.46M, up 19.5% from fiscal 2025. Compound annual growth was +31.6% over 5 years. It rose in each of the last 6 fiscal years. Fiscal 2026 is the highest of the 7 fiscal years on file.
| Line item | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $644.86M | $570.40M | $475.42M | $419.05M | $343.55M | $206.90M | $116.39M |
| Cost of revenue | $70.33M | $55.87M | $50.67M | $53.49M | $39.79M | $31.20M | $14.90M |
| Gross profit | $574.54M | $514.52M | $424.75M | $365.56M | $303.76M | $175.70M | $101.49M |
| Research and development | $130.70M | $93.04M | $81.98M | $80.19M | $62.35M | $43.87M | $32.44M |
| Selling, general and admin | $65.27M | $45.67M | $37.83M | $36.74M | $35.75M | $16.49M | $7.44M |
| Operating income | $214.92M | $227.80M | $163.88M | $125.11M | $113.54M | $53.30M | $22.16M |
| Pre-tax income | $250.00M | $263.57M | $185.20M | $133.16M | $114.00M | $57.77M | $23.51M |
| Income tax | $53.95M | $40.39M | $37.62M | $20.34M | -$40.78M | $7.56M | -$6.22M |
| Net income | $196.05M | $223.19M | $147.58M | $112.82M | $154.78M | $50.21M | $29.74M |
| EPS, basic | $1.05 | $1.19 | $0.78 | $0.58 | $0.82 | $0.29 | $0.16 |
| EPS, diluted | $0.98 | $1.11 | $0.72 | $0.53 | $0.70 | $0.23 | $0.13 |
| Diluted shares | 199.0M | 201.2M | 205.7M | 213.4M | 191.0M | 95.1M | 81.7M |
| Line item | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | $219.18M | $209.61M | $96.78M | $158.03M | $112.81M | $66.39M | $48.43M |
| Receivables | $144.78M | $128.35M | $101.33M | $107.05M | $81.07M | $50.32M | - |
| Current assets | $944.26M | $1.09B | $912.94M | $975.45M | $904.14M | $209.40M | - |
| Goodwill | $84.97M | $67.94M | $67.94M | $67.94M | $18.91M | $18.91M | - |
| Total assets | $1.12B | $1.26B | $1.08B | $1.14B | $991.36M | $251.72M | - |
| Current liabilities | $154.97M | $156.26M | $147.25M | $139.51M | $111.28M | $102.04M | - |
| Total liabilities | $172.85M | $181.68M | $177.98M | $170.77M | $112.76M | $103.52M | - |
| Shareholders' equity | $950.84M | $1.08B | $901.40M | $966.12M | $878.59M | $66.74M | $1.14M |
| Line item | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $326.46M | $273.26M | $184.10M | $179.60M | $126.58M | $82.97M | $26.20M |
| Capital expenditures | $0 | $0 | $147.0K | $1.70M | $1.91M | $245.0K | $285.0K |
| Free cash flow | $326.46M | $273.26M | $183.95M | $177.90M | $124.66M | $82.73M | $25.91M |
| Investing cash flow | $147.17M | -$29.30M | $31.19M | -$59.92M | -$640.57M | -$70.42M | -$13.10M |
| Financing cash flow | -$464.06M | -$131.14M | -$276.52M | -$74.46M | $560.41M | $5.41M | $1.72M |
| Share repurchases | $431.65M | $120.29M | $280.72M | $85.32M | $2.70M | $2.02M | $0 |
| Stock-based compensation | $121.63M | $72.39M | $51.08M | $47.83M | $31.44M | $7.25M | $2.35M |
| Depreciation and amortization | $14.38M | $10.66M | $10.27M | $10.28M | $5.04M | $3.70M | $900.0K |
| Line item | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 |
|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | 13.1% | 20.0% | 13.5% | 22.0% | 66.0% | 77.8% | - |
| Net income growth, YoY | -12.2% | 51.2% | 30.8% | -27.1% | 208.3% | 68.8% | - |
| EPS growth, YoY | -11.7% | 54.2% | 35.8% | -24.3% | - | 76.9% | - |
| Gross margin | 89.1% | 90.2% | 89.3% | 87.2% | 88.4% | 84.9% | 87.2% |
| Operating margin | 33.3% | 39.9% | 34.5% | 29.9% | 33.0% | 25.8% | 19.0% |
| Net margin | 30.4% | 39.1% | 31.0% | 26.9% | 45.1% | 24.3% | 25.5% |
| Free cash flow margin | 50.6% | 47.9% | 38.7% | 42.5% | 36.3% | 40.0% | 22.3% |
| Return on equity | 20.6% | 20.6% | 16.4% | 11.7% | 17.6% | 75.2% | 2617.7% |
| Return on assets | 17.4% | 17.7% | 13.7% | 9.9% | 15.6% | 19.9% | - |
| Current ratio | 6.09 | 6.97 | 6.20 | 6.99 | 8.12 | 2.05 | - |
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $174.54M | $156.62M | $145.37M | $185.05M | $168.53M | $145.91M | $138.29M | $168.60M | $136.83M | $126.68M | $118.06M | $135.28M |
| Cost of revenue | $25.35M | $23.69M | $19.41M | $18.70M | $16.43M | $15.79M | $14.47M | $14.18M | $13.68M | $13.55M | $12.57M | $12.19M |
| Gross profit | $149.19M | $132.93M | $125.97M | $166.35M | $152.10M | $130.12M | $123.82M | $154.42M | $123.16M | $113.13M | $105.49M | $123.09M |
| Research and development | $41.96M | $38.48M | $39.11M | $34.59M | $30.20M | $26.80M | $24.80M | $22.42M | $23.24M | $22.57M | $20.15M | $19.95M |
| Selling, general and admin | $16.42M | $15.76M | $16.12M | $17.66M | $19.05M | $12.44M | $12.73M | $13.59M | $10.10M | $9.26M | $9.97M | $9.64M |
| Operating income | $43.92M | $33.64M | $24.83M | $71.90M | $63.68M | $54.52M | $48.68M | $79.92M | $53.14M | $46.05M | $41.85M | $58.55M |
| Pre-tax income | $50.33M | $40.36M | $32.12M | $80.80M | $72.94M | $64.15M | $58.39M | $89.84M | $62.17M | $53.17M | $47.95M | $63.03M |
| Income tax | $15.60M | $16.05M | $13.01M | $19.24M | $10.88M | $10.83M | -$4.06M | $14.64M | $18.02M | $11.79M | $7.33M | $15.08M |
| Net income | $34.73M | $24.32M | $19.11M | $61.56M | $62.06M | $53.32M | $62.46M | $75.20M | $44.15M | $41.38M | $40.62M | $47.96M |
| EPS, basic | $0.19 | $0.13 | $0.11 | $0.33 | $0.33 | $0.28 | $0.33 | $0.40 | $0.24 | $0.22 | $0.21 | $0.26 |
| EPS, diluted | $0.18 | $0.13 | $0.09 | $0.31 | $0.31 | $0.27 | $0.31 | $0.37 | $0.22 | $0.21 | $0.20 | $0.24 |
| Diluted shares | 187.8M | 191.2M | - | 199.2M | 200.7M | 201.2M | - | 202.2M | 200.4M | 199.2M | - | 200.5M |
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $218.61M | $273.60M | $219.18M | $64.84M | $169.25M | $137.26M | $209.61M | $165.27M | $184.25M | $111.44M | $96.78M | $123.09M |
| Receivables | $166.11M | $177.57M | $144.78M | $156.59M | $129.31M | $141.66M | $128.35M | $137.50M | $124.79M | $120.91M | $101.33M | $97.58M |
| Current assets | $921.54M | $913.98M | $944.26M | $993.45M | $1.09B | $1.03B | $1.09B | $1.01B | $957.71M | $908.47M | $912.94M | $840.90M |
| Goodwill | $84.97M | $84.97M | $84.97M | $84.97M | $84.97M | $67.94M | $67.94M | $67.94M | $67.94M | $67.94M | $67.94M | $67.94M |
| Total assets | $1.09B | $1.08B | $1.12B | $1.16B | $1.26B | $1.20B | $1.26B | $1.17B | $1.12B | $1.07B | $1.08B | $1.00B |
| Current liabilities | $144.59M | $150.36M | $154.97M | $149.85M | $140.27M | $159.91M | $156.26M | $115.88M | $132.28M | $135.28M | $147.25M | $104.76M |
| Total liabilities | $163.29M | $167.78M | $172.85M | $177.73M | $161.58M | $178.85M | $181.68M | $141.04M | $157.32M | $159.88M | $177.98M | $136.03M |
| Shareholders' equity | $928.48M | $916.07M | $950.84M | $979.30M | $1.10B | $1.03B | $1.08B | $1.03B | $961.20M | $913.58M | $901.40M | $864.61M |
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $93.28M | $41.99M | $109.52M | $60.89M | $93.94M | $62.10M | $98.49M | $65.19M | $68.35M | $41.24M | $63.94M | $50.05M |
| Capital expenditures | $0 | $62.0K | - | - | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $36.0K |
| Free cash flow | $93.28M | $41.92M | - | - | $93.94M | $62.10M | $98.49M | $65.19M | $68.35M | $41.24M | $63.94M | $50.02M |
| Investing cash flow | -$84.03M | $112.99M | $137.98M | $38.23M | -$31.71M | $2.68M | -$24.47M | -$58.92M | $24.16M | $29.94M | -$76.17M | $40.13M |
| Financing cash flow | -$64.24M | -$100.55M | -$93.16M | -$203.53M | -$30.25M | -$137.13M | -$29.67M | -$25.24M | -$19.70M | -$56.53M | -$14.08M | -$75.50M |
| Share repurchases | $54.20M | $91.63M | $90.53M | $196.88M | $21.89M | $122.36M | $26.79M | $19.31M | $22.98M | $51.21M | $17.74M | $76.79M |
| Stock-based compensation | $40.56M | $36.75M | $36.74M | $33.55M | $29.47M | $21.86M | $18.06M | $19.37M | $17.87M | $17.09M | $11.86M | $11.77M |
| Depreciation and amortization | $4.35M | $4.29M | $4.13M | $3.99M | $3.47M | $2.79M | $2.83M | $2.65M | $2.61M | $2.56M | $2.55M | $2.51M |
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | 3.6% | 7.3% | 5.1% | 9.8% | 23.2% | 15.2% | 17.1% | 24.6% | 20.4% | 16.8% | 6.4% | 17.4% |
| Net income growth, YoY | -44.0% | -54.4% | -69.4% | -18.1% | 40.6% | 28.9% | 53.8% | 56.8% | 44.3% | 45.7% | 32.4% | 43.3% |
| EPS growth, YoY | -41.9% | -51.9% | -71.0% | -16.2% | 40.9% | 28.6% | 55.0% | 54.2% | 46.7% | 61.5% | 33.3% | 50.0% |
| Gross margin | 85.5% | 84.9% | 86.7% | 89.9% | 90.3% | 89.2% | 89.5% | 91.6% | 90.0% | 89.3% | 89.4% | 91.0% |
| Operating margin | 25.2% | 21.5% | 17.1% | 38.9% | 37.8% | 37.4% | 35.2% | 47.4% | 38.8% | 36.4% | 35.5% | 43.3% |
| Net margin | 19.9% | 15.5% | 13.1% | 33.3% | 36.8% | 36.5% | 45.2% | 44.6% | 32.3% | 32.7% | 34.4% | 35.4% |
| Free cash flow margin | 53.4% | 26.8% | - | - | 55.7% | 42.6% | 71.2% | 38.7% | 49.9% | 32.6% | 54.2% | 37.0% |
| Current ratio | 6.37 | 6.08 | 6.09 | 6.63 | 7.79 | 6.47 | 6.97 | 8.74 | 7.24 | 6.72 | 6.20 | 8.03 |
Source: XBRL data Doximity Inc. files with the SEC, latest filing dated Nov 5, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| DOCS | $661.58M | +6.5% | $139.72M | 21.1% | $5.86B |
| VEEV | $3.46B | +16.5% | $1.01B | 29.3% | $49.61B |
| HCAT | $272.20M | -13.9% | -$202.09M | -74.2% | $115.0M |
| TDOC | $2.47B | -2.4% | -$154.82M | -6.3% | $1.64B |
| PHR | $507.79M | +12.9% | $10.45M | 2.1% | $800.4M |
| HSTM | $327.95M | +9.8% | $20.49M | 6.2% | $883.8M |
| EVH | $2.34B | +14.1% | -$507.69M | -21.7% | $532.1M |